Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.
about
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsRelative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study.An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.Low-dose dexamethasone challenge in women with atypical major depression: pilot study.Stress hormone-related psychopathology: pathophysiological and treatment implications.Lack of elevations in glucocorticoids correlates with dysphoria-like behavior after repeated social defeat.Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disordersGlucocorticoid receptor function in vitro in patients with major depression.The glucocorticoid receptor: part of the solution or part of the problem?Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors.Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?In vitro modulation of the glucocorticoid receptor by antidepressants.Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.The glucocorticoid receptor: pivot of depression and of antidepressant treatment?Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Dexamethasone in the presence of desipramine enhances MAPK/ERK1/2 signaling possibly via its interference with β-arrestin.Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones.
P2860
Q24618470-C70D0F34-85B7-4C62-98ED-826DE1B9600BQ33763259-B1F3409F-75D6-4205-93DF-EE3EE51D7DBEQ34220649-50FFF84A-CD77-46FD-A705-F910058F8A77Q34758357-B22E21EE-2972-4041-A9A7-5FBB1DB9DE2EQ35066496-6A27F48F-8BA9-404F-8E90-1DA05F6F3450Q36072915-CA12FE89-3683-4BBD-9E23-552A75C0FB60Q36169850-6E244495-0F6C-41B8-9731-288B22B14ABDQ36194741-36455F84-0A11-43B9-BD2A-DF925B8CCEC9Q36511702-C5972651-DE04-4DA6-9B2A-F05FB543F093Q37169684-5FC084B0-EACB-4482-A8C6-11F7105DDE96Q37183514-CBA20B19-8460-44B0-B564-A012FFD6E5E8Q37344256-C113CE67-017A-46C4-B3D4-204F97550848Q37631141-C6E2251E-D4B0-4B2A-A26F-3C0CCB12B59CQ37732806-A44C503F-A173-4987-B20A-517C5B0DF4A2Q38203227-F5B143B7-3C72-455A-B6BF-39CB0B1139A1Q39077634-B352CFA4-9E03-4415-BC43-362CECC187B8Q41947488-F2B7BE49-DA80-4B00-8DDF-012126DE82B2Q44464123-1C9EFBD9-5F71-4E8B-B3E5-314E6307C22B
P2860
Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@en
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@nl
type
label
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@en
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@nl
prefLabel
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@en
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@nl
P2093
P2860
P1476
Prednisone augmentation in tre ...... ocortisolaemia: a case series.
@en
P2093
P2860
P356
10.1002/1520-6394(2000)12:1<44::AID-DA6>3.0.CO;2-C
P577
2000-01-01T00:00:00Z